Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
- Status
- TERMINATED
- Phase
- PHASE1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
- Status
- COMPLETED
- Phase
- N/A
Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- NA
Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE1
Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
- Status
- COMPLETED
- Phase
- PHASE1
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- Status
- RECRUITING
- Phase
- PHASE2
Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
- Status
- COMPLETED
- Phase
- PHASE2
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
- Status
- UNKNOWN
- Phase
- PHASE2
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
- Status
- TERMINATED
- Phase
- N/A
Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM
- Status
- COMPLETED
- Phase
- PHASE1